Home>Topics>Companies>McKesson

McKesson MCK

  1. All
  2. Commentary
  3. Headlines
    1. Cramer's Lightning Round - Downgrade Apple All You Want (10/3/14)

      Headlines

      Sun, 5 Oct 2014

      the trajectory of the earnings." McKesson (NYSE: MCK ): "The one company I haven't recommended enough is McKesson ." KKR (NYSE: KKR ): "It is a ..... Omnicare (NYSE: OCR ) : Cramer prefers McKesson . Kandi Technologies (NASDAQ: KNDI

    2. Rite Aid's Recent Sell-Off Provides Opportunity For Long-Term Value Investors With $6.60 Fair Value Price Target

      Headlines

      Wed, 24 Sep 2014

      buying opportunity. Management's 2015 guidance was revised downward due to reimbursement pressures, the delay of the McKesson benefit, and the delay of the generic Nexium launch. However, I do not believe any of these issues represents a serious

    3. From Barron’s, September 22, 2014 (Part 2)

      Commentary

      Sat, 20 Sep 2014

      hub and Apple Pay functions; pg 30]; Vitamin Shoppe [ VSI ; pg 39]; drug and healthcare supplies distributor McKesson [ MCK ; CEO spotlight on John Hammergren ; pg 40]. GNW story http://online.barrons.com/news/articles/SB52133021052493823286804580158270334723144

    4. Don’t Ignore Higher Taxes Until Tax Day

      Headlines

      Mon, 18 Aug 2014

      The company is one of the smallest players in the medical distribution field, which is dominated by giants such as McKesson MCK and Cardinal Health CAH. Yet it has persistently increased its market share within the small niche it occupies (the

    5. McKesson Reports In-Line First Quarter as Celesio Buoys the Firm's Results

      Commentary

      Thu, 31 Jul 2014

      McKesson reported results for its fiscal first quarter ..... 177 fair value estimate. Helping to boost McKesson 's operations was the recent Celesio acquisition ..... a positive strategic move that enhances McKesson ’s supplier purchasing power and solidifies

    6. Credit Market Outlook: Tight Spreads Will Keep a Lid on Returns

      Headlines

      Thu, 26 Jun 2014

      the first half of 2014, we downgraded Actavis ACT "> ACT , Bayer BAYRY "> BAYRY , Mallinckrodt MNK "> MNK , McKesson MCK "> MCK , Novartis NVS "> NVS , and Zimmer ZMH "> ZMH because of these events. Also, in early 2014, Baxter BAX

    7. UPDATE 1-Hedge fund sues McKesson for $500 mln over Celesio deal

      Headlines

      Wed, 21 May 2014

      * Magnetar says minority Celesio shareholders short changed

    8. After Our Review, We Believe McKesson ’s Recent Acquisition of Celesio Will Strengthen Its Operations

      Commentary

      Mon, 19 May 2014

      We believe McKesson ’s recent acquisition of major European ..... distribution advantages should benefit McKesson operationally. The firm will have the ..... Additionally, by acquiring Celesio, McKesson cements its status as the premier global

    9. McKesson MCK Q4 2014 Earnings Call Transcript

      Headlines

      Mon, 12 May 2014

      afternoon, everyone, and welcome to the McKesson Corporation Quarterly Earnings Call ..... Good afternoon and welcome to the McKesson fiscal 2014 fourth quarter earnings ..... joined today by John Hammergren, McKesson 's Chairman and CEO; and James

    10. Celesio says recommends offer from McKesson

      Headlines

      Wed, 11 Dec 2013

      FRANKFURT, Dec 11 (Reuters) - German drugs wholesaler Celesio said its supervisory and management board recommended shareholders accept the $8.3 billion takeover offer from McKesson Corp . and viewed...

    « Prev12345Next »
    Content Partners